Literature DB >> 11054477

cGMP-dependent protein kinase mediates stimulation of L-type calcium current by cGMP in rabbit atrial cells.

Y Wang1, M B Wagner, R W Joyner, R Kumar.   

Abstract

OBJECTIVES: cGMP has been shown to exert both stimulatory and inhibitory effects on cardiac L-type calcium current (I(Ca)). The physiological role of cGMP in regulation of cardiac activity is still controversial. cGMP may be of importance in regulation of I(Ca) in atrial cells. The present study was focused on the role of cGMP in the modulation of I(Ca) in rabbit atrial cells.
METHODS: Enzymatically isolated adult rabbit atrial cells were used to measure I(Ca) using whole cell voltage clamp. Expressed levels of cGMP-dependent protein kinase (PKG) were determined by Western blotting using PKG specific antibody in homogenates from atrial and ventricular cells.
RESULTS: Nitrosoglutathione (GSNO), a nitric oxide donor that stimulates soluble guanylyl-cyclase to elevate cGMP levels increased I(Ca) while soluble G-cyclase inhibitors, ODQ or methylene blue inhibited I(Ca). Intracellular application of 8BrcGMP increased I(Ca) and blocked the inhibitory effect of methylene blue. KT-5823, an inhibitor of PKG inhibited I(Ca) and the stimulatory effect of GSNO was completely blocked ODQ or KT-5823. Inhibition of cAMP dependent protein kinase (PKA) by the 6-22 peptide completely blocked the stimulation of I(Ca) by the beta-agonist isoproterenol but not by GSNO. The potency of isoproterenol to stimulate I(Ca) was very high for atrial cells (EC(50) 2.4+/-0.6 nM) and only 100 nM isoproterenol was required to stimulate I(Ca) maximally (21.4+/-0.7 pA/pF) to a level (23.8+/-1.6 pA/pF) achieved with the inclusion of 100 microM cAMP in the pipette solution. GSNO produced an additive effect on I(Ca) already stimulated by either 10 microM isobutylmethylxanthine (phosphodiesterase inhibitor) or a low concentration (1 nM) isoproterenol but failed to produce any effect on I(Ca) maximally stimulated by 100 nM isoproterenol. Inhibition of PKG by KT-5823 significantly decreased the efficacy of isoproterenol and the maximal I(Ca) achieved with 100 nM isoproterenol was decreased to 8.2+/-0.6 pA/pF in the presence of KT-5823. Western blot analysis showed much higher expression of PKG in atrial cells compared to ventricular cells.
CONCLUSIONS: These findings suggest that stimulatory effects of cGMP on I(Ca) in rabbit atrial cells are likely to be mediated via PKG dependent phosphorylation of calcium channels or associated proteins and that the effects of cGMP are not antagonistic to cAMP. PKG is highly expressed in atrial cells and PKG dependent phosphorylation may be necessary for maintaining basal I(Ca) and fully stimulating I(Ca) by beta-adrenergic activation in atrial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054477     DOI: 10.1016/s0008-6363(00)00178-4

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  9 in total

1.  CaMKII inhibition in heart failure, beneficial, harmful, or both.

Authors:  Jun Cheng; Lin Xu; Dongwu Lai; Arnaud Guilbert; Hyun Joung Lim; Thitima Keskanokwong; Yanggan Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

2.  Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation.

Authors:  Nadiia Rozmaritsa; Torsten Christ; David R Van Wagoner; Hannelore Haase; Johannes-Peter Stasch; Klaus Matschke; Ursula Ravens
Journal:  Cardiovasc Res       Date:  2013-12-12       Impact factor: 10.787

Review 3.  Calcineurin-dependent ion channel regulation in heart.

Authors:  Yanggan Wang; Samvit Tandan; Joseph A Hill
Journal:  Trends Cardiovasc Med       Date:  2013-07-01       Impact factor: 6.677

4.  NO donors potentiate the beta-adrenergic stimulation of I(Ca,L) and the muscarinic activation of I(K,ACh) in rat cardiac myocytes.

Authors:  Najah Abi-Gerges; Gabor Szabo; Angela S Otero; Rodolphe Fischmeister; Pierre-François Méry
Journal:  J Physiol       Date:  2002-04-15       Impact factor: 5.182

5.  Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure.

Authors:  Yanggan Wang; Samvit Tandan; Jun Cheng; Chunmei Yang; Lan Nguyen; Jessica Sugianto; Janet L Johnstone; Yuyang Sun; Joseph A Hill
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

6.  Potentiation of slow component of delayed rectifier K(+) current by cGMP via two distinct mechanisms: inhibition of phosphodiesterase 3 and activation of protein kinase G.

Authors:  Kentaro Shimizu; Yutaka Shintani; Wei-Guang Ding; Hiroshi Matsuura; Tadao Bamba
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 7.  Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.

Authors:  Yuan James Rao; Lei Xi
Journal:  Acta Pharmacol Sin       Date:  2008-12-08       Impact factor: 6.150

8.  Reduced density and altered regulation of rat atrial L-type Ca2+ current in heart failure.

Authors:  Richard C Bond; Simon M Bryant; Judy J Watson; Jules C Hancox; Clive H Orchard; Andrew F James
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-06       Impact factor: 4.733

9.  Natriuretic peptide receptor B maintains heart rate and sinoatrial node function via cyclic GMP-mediated signalling.

Authors:  Tristan W Dorey; Martin Mackasey; Hailey J Jansen; Megan D McRae; Loryn J Bohne; Yingjie Liu; Darrell D Belke; Logan Atkinson; Robert A Rose
Journal:  Cardiovasc Res       Date:  2022-06-29       Impact factor: 13.081

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.